Ruffini's endings are ____. a. elaborate neuron endings for touch b. simple, bare neuron endings ...

Author Question: Ruffini's endings are ____. a. elaborate neuron endings for touch b. simple, bare neuron endings ... (Read 210 times)

jazziefee

Hero Member
Posts: 505

on: Jun 22, 2018

Ruffini's endings are ____.

a. elaborate neuron endings for touch
b. simple, bare neuron endings
c. bare endings surrounded by non-neural cells
d. important components of the blood

Question 2

Most depressed people have decreased activity in the left and increased activity in the right prefrontal cortex.

a. True
b. False
Indicate whether the statement is true or false

yasmin

Sr. Member
Posts: 319

Reply #1 on: Jun 22, 2018

Answer to Question 1

a

Answer to Question 2

True

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Though the United States has largely rejected the metric system, it is used for currency, as in 100 pennies = 1 dollar. Previously, the British currency system was used, with measurements such as 12 pence to the shilling, and 20 shillings to the pound.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.